Emtricitabine, Rilpivirine, Tenofovir Disoproxil Fumarate

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 0378-5440
  • Package NDC 0378-5440-93
  • Application number ANDA208452
  • SPL ID d9a4185e-43fa-4aeb-9b0f-8db01b166038
  • SPL set ID d9a4185e-43fa-4aeb-9b0f-8db01b166038
  • UNII G70B4ETF4S
  • UNII 212WAX8KDD
  • UNII OTT9J7900I
  • RxCUI 1147334

What the source publishes

Labeler
Mylan Pharmaceuticals Inc.
Active ingredients
Emtricitabine, Rilpivirine, Tenofovir Disoproxil Fumarate
Form
TABLET, FILM COATED
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:0378-5440_d9a4185e-43fa-4aeb-9b0f-8db01b166038
{
  "name": "Emtricitabine, Rilpivirine, Tenofovir Disoproxil Fumarate",
  "splId": "d9a4185e-43fa-4aeb-9b0f-8db01b166038",
  "labels": [
    {
      "setId": "d9a4185e-43fa-4aeb-9b0f-8db01b166038",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d9a4185e-43fa-4aeb-9b0f-8db01b166038",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d9a4185e-43fa-4aeb-9b0f-8db01b166038"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Mylan Pharmaceuticals Inc.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-5440-93)",
      "package_ndc": "0378-5440-93",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20250527"
    }
  ],
  "productId": "0378-5440_d9a4185e-43fa-4aeb-9b0f-8db01b166038",
  "useDomain": "unknown",
  "dosageForm": "TABLET, FILM COATED",
  "productNdc": "0378-5440",
  "deaSchedule": null,
  "genericName": "Emtricitabine, Rilpivirine, Tenofovir Disoproxil Fumarate",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "EMTRICITABINE",
      "strength": "200 mg/1"
    },
    {
      "name": "RILPIVIRINE HYDROCHLORIDE",
      "strength": "25 mg/1"
    },
    {
      "name": "TENOFOVIR DISOPROXIL FUMARATE",
      "strength": "300 mg/1"
    }
  ],
  "applicationNumber": "ANDA208452",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20250527",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000175462",
      "M0015066",
      "N0000009947"
    ],
    "unii": [
      "G70B4ETF4S",
      "212WAX8KDD",
      "OTT9J7900I"
    ],
    "rxcui": [
      "1147334"
    ],
    "spl_set_id": [
      "d9a4185e-43fa-4aeb-9b0f-8db01b166038"
    ],
    "pharm_class_cs": [
      "Nucleosides [CS]"
    ],
    "pharm_class_epc": [
      "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"
    ],
    "pharm_class_moa": [
      "Nucleoside Reverse Transcriptase Inhibitors [MoA]"
    ],
    "manufacturer_name": [
      "Mylan Pharmaceuticals Inc."
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:0378-5440_d9a4185e-43fa-4aeb-9b0f-8db01b166038"